Chinese biopharma firm DAC Biotech nets $156m co-led by GL Ventures
Chinese biopharma firm DAC Biotech nets $156m co-led by GL Ventures Source: Jan Antonin Kolar/Unsplash May 12, 2021 Biopharmaceutical firm Hangzhou DAC Biotech Co., Ltd has announced the completion of a 1 billion yuan ($156 million) Series C round co-led by PE firm Hillhouse Capital’s venture unit GL Ventures. State-backed CITIC Private Equity Funds Management (CPE), and CDG Capital — a Hong Kong-based investment firm that has invested in healthcare startups like Innovent, Akeso, and Grail — were the co-lead investors, DAC Biotech said in a WeChat post on May 8. It also attracted new...
Source: dealstreetasia.com